Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSPIC: Prednisone for Post-infectious Cough
NCT04232449Phase 3Terminated
- Sponsor
- University Hospital Basel
- Start
- Nov 2020
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisone in postinfectious cough (2 arms), sponsored by University Hospital Basel. Primary endpoint: Leicester Cough Questionnaire at 14 days. Started Nov 2020; status: terminated.
02
Drugs
prednisone
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on NCT04232449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04232449.